Foghorn Therapeutics Inc. - Common Stock - Çeyreklik Bilanço (NASDAQ:FHTX) | MetaTrader

Tam grafiği aç Full chart

Haberler

CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates

Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Top Estimates

Foghorn Therapeutics Inc. (FHTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Tops Revenue Estimates

Stifel, Foghorn Therapeutics için hisse tavsiyesini korudu

H.C. Wainwright, Foghorn Therapeutics için al tavsiyesini korudu

Foghorn kanser ilaç adayları için preklinik veri sundu

Foghorn, AACR toplantısında kanser verileri sunacak

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Citizens, Foghorn Therapeutics hissesi için hedef fiyatını korudu

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress